Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as a First-Line Therapy for Never-Smokers with Adenocarcinoma of the Lung and Asymptomatic Synchronous Brain Metastasis

Kinase Inhibitors ◽

Growth Factor Receptor ◽

First Line ◽

Adenocarcinoma Of The Lung ◽

First Line Therapy ◽

Line Therapy ◽

Epidermal Growth ◽

Never Smokers ◽

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis

Lung Cancer ◽

10.1016/j.lungcan.2008.12.011 ◽

2009 ◽

Vol 65 (3) ◽

pp. 351-354 ◽

Cited By ~ 144

Author(s):

Jeong-Eun Kim ◽

Dae Ho Lee ◽

Yunsuk Choi ◽

Dok Hyun Yoon ◽

Sang-We Kim ◽

...

Keyword(s):

Kinase Inhibitors ◽

Growth Factor Receptor ◽

First Line ◽

Adenocarcinoma Of The Lung ◽

First Line Therapy ◽

Line Therapy ◽

Epidermal Growth ◽

Never Smokers ◽

Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancer

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000268 ◽

2015 ◽

Vol 26 (9) ◽

pp. 995-1003 ◽

Cited By ~ 10

Author(s):

Sávia R.C. Normando ◽

Felipe M. Cruz ◽

Auro del Giglio

Keyword(s):

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Epidermal Growth

Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis

Anticancer Research ◽

10.21873/anticanres.15331 ◽

2021 ◽

Vol 41 (10) ◽

pp. 5137-5145

Author(s):

SHO MITSUYA ◽

KENJIRO TSURUOKA ◽

KIYOE KANAOKA ◽

TOMOYA FUNAMOTO ◽

HIROYUKI TSUJI ◽

...

Keyword(s):

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Third Generation ◽

Small Cell Lung ◽

First Line ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors ◽

First Line Treatment

Cost-effectiveness analysis of tyrosine kinase inhibitors (erlotinib, gefitinib, afatinib and osimertinib) as first-line therapy for epidermal growth factor receptor-mutated advanced non-small cell lung cancer

Journal of Chinese Pharmaceutical Sciences ◽

10.5246/jcps.2021.03.021 ◽

2021 ◽

Vol 30 (3) ◽

pp. 253-263

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Effectiveness Analysis ◽

Line Therapy ◽

Epidermal Growth

Abstract 4849: An association between genetic variant inEpidermal Growth Factor(EGF) gene and survival benefit from epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in never smokers with advanced adenocarcinoma of the lung.

10.1158/1538-7445.am2013-4849 ◽

2013 ◽

Author(s):

Youngjoo Lee ◽

Kyong-Ah Yoon ◽

Jin Soo Lee

Keyword(s):

Growth Factor ◽

Survival Benefit ◽

Kinase Inhibitors ◽

Genetic Variant ◽

Growth Factor Receptor ◽

Adenocarcinoma Of The Lung ◽

Epidermal Growth ◽

Never Smokers ◽

Egfr Tkis

Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer

Current Opinion in Oncology ◽

10.1097/cco.0b013e32833500d2 ◽

2010 ◽

Vol 22 (2) ◽

pp. 112-120 ◽

Cited By ~ 32

Author(s):

Rafael Rosell ◽

Santiago Viteri ◽

Miguel Angel Molina ◽

Susana Benlloch ◽

Miquel Taron

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Nonsmall Cell Lung Cancer ◽

Line Treatment ◽

First Line ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors ◽

First Line Treatment

Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

PLoS ONE ◽

10.1371/journal.pone.0123587 ◽

2015 ◽

Vol 10 (5) ◽

pp. e0123587 ◽

Cited By ~ 18

Author(s):

Amit Jain ◽

Cindy Lim ◽

Eugene MingJin Gan ◽

David Zhihao Ng ◽

Quan Sing Ng ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Brain Metastasis ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Growth Factor Receptor ◽

First Line ◽

Epidermal Growth ◽

T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors

Lung India ◽

10.4103/lungindia.lungindia_182_19 ◽

2020 ◽

Vol 37 (1) ◽

pp. 13 ◽

Cited By ~ 1

Author(s):

Laksmi Wulandari ◽

Vinodini Merinda ◽

Gatot Soegiarto

Keyword(s):

Epidermal Growth Factor Receptor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Circulating Tumor Dna ◽

First Line ◽

Dna Test ◽

Epidermal Growth ◽

Tumor Dna ◽

Observational Study of Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (Egfr-Tki) in Activating Egfr Mutation-Positive (Egfrm+) Advanced or Recurrent Non-Small-Cell Lung Cancer (Nsclc) After Radiological Progression to First-Line Therapy with Egfr-Tki

Annals of Oncology ◽

10.1093/annonc/mdu349.69 ◽

2014 ◽

Vol 25 ◽

pp. iv454 ◽

Cited By ~ 1

Author(s):

Y. Yamane ◽

H. Sakai ◽

F. Kurimoto ◽

J. Sudo ◽

H. Tsuzuki ◽

...

Keyword(s):

Kinase Inhibitors ◽

Egfr Mutation ◽

Growth Factor Receptor ◽

First Line ◽

Radiological Progression ◽

First Line Therapy ◽

Activating Egfr Mutation ◽

Epidermal Growth ◽

Egfr Tki

FEASIBILITY AND CLINICAL IMPACT OF RE-BIOPSY IN ADVANCED LUNG ADENOCARCINOMA AFTER PROGRESSES DURING FIRST-LINE EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS

Respirology ◽

10.1111/resp.13419_13 ◽

2018 ◽

Vol 23 ◽

pp. 9-9

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Clinical Impact ◽

First Line ◽

Epidermal Growth ◽